Nonsteroidal Anti-Inflammatory Drugs-The Clinical Dilemmas

References

• Semble E L, Wu W C. Anti-inflammatory drugs and gastric mucosal damage. Semin Arthritis Rheum 1987; 16(4)271–286
   PubMedGoogle Scholar
• Larkai E M, Lacey Smith J, Lidsky M D, Graham D Y. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 1987; 82: 1153–8
   PubMed Web of Science ®Google Scholar
• Katzka D A, Sunshine A G, Cohen S. The effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract symptoms and mucosal integrity. J Clin Gastroenterol 1987; 9: 142–8
   PubMedGoogle Scholar
• Butt J H, Barthel J S, Moore R A. Clinical spectrum of the upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Am J Med 1988; 84: 5–14, Suppl 2A
   PubMedGoogle Scholar
• Larkai E N, Smith L, Sessoms S L, Graham D Y. Dyspepsia in NSAID users: the size of the problem. J Clin Gastroenterol 1989; 11: 158–62
   PubMed Web of Science ®Google Scholar
• Bjilsma J WJ, Multicenter Group. Treatment of endoscopy-negative NSAID-induced upper gastrointestinal symptoms with cimetidine: an international multicenter collaborative study. Aliment Pharmacol Ther 1988; 2S: 75–83
   Google Scholar
• Armstrong C P, Blower A L. Nonsteroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration. Gut 1987; 28: 527–32
   PubMed Web of Science ®Google Scholar
• Jones S TM, Clague R B, Eldridge J, Jones D M. Serologic evidence of infection with H. Pylori may predict gastrointestinal intolerance to nonsteroidal anti-inflammatory drug (NSAID) treatment in rheumatoid arthritis. Br J Rheumatol 1991; 30: 16–20
   PubMedGoogle Scholar
• Caldwell J R, Roth A SH, Wu W C, et al. Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage. Am J Med 1987; 83: 74–82, Suppl 38
   PubMed Web of Science ®Google Scholar
• McCarthy D M. Nonsteroidal anti-inflammatory drug-induced ulcers: management by traditional therapies. Gastroenterology 1989; 96: 662–74
   PubMed Web of Science ®Google Scholar
• Tympner F. Gastroscopic findings after therapy with non-steroid anti-rheumatic drugs. Z Rheumatol 1981; 40: 179–81
   PubMed Web of Science ®Google Scholar
• Lanas A, Hirschowitz B I. Significant role of aspirin use in esophagitis. Gastroenterology 1991; 100(5 part II)A106
   Google Scholar
• Wallin B A, Grier C E, Fox M J, McCafferty J P, Wetherington J D, Palmer R H. Prevention of NSAID-induced ulcers with cimetidine: results of a double-blind, placebo-controlled trial. Gastroenterology 1990; 98: A146
   PubMedGoogle Scholar
• Hawkey C J. Nonsteroidal anti-inflammatory drugs and peptic ulcers. Br Med J 1990; 300: 278–84
   PubMed Web of Science ®Google Scholar
• Gabriel S E, Jaakminainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs–a meta-analysis. Ann Intern Med 1991; 115: 787–96
   PubMed Web of Science ®Google Scholar
• Kurata J H, Abbey D E. The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. J Clin Gastroenterol 1990; 12: 260–6
   PubMed Web of Science ®Google Scholar
• Somerville K, Faulkner G, Langman M. Nonsteroidal antiinflammatory drugs and bleeding peptic ulcer. Lancet 1986; 1: 462–4
   PubMed Web of Science ®Google Scholar
• Quadar K, Logan R F. Peptic ulcer (PU) deaths: how many occur at home or after nonsteroidal anti-inflammatory drug (NSAID) prescribing?. Gut 1988; 29: A1443
   Google Scholar
• Griffin M R, Piper J M, Daugherty J R, Snowden M, Ray W A. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Interm Med 1991; 114: 257–63
   PubMed Web of Science ®Google Scholar
• Henry D A, Johnston A, Dobson A, Duggan J. Fatal peptic ulcer complications and the use of nonsteroidal anti-inflammatory drugs, aspirin and corticosteroids. Br Med J 1987; 295: 1227–9
   PubMedGoogle Scholar
• Saleeby G, Holt L, Holt S. Pattern and prevalence of nonsteroidal anti-inflammatory drug (NSAID) use in complicated peptic ulcer disease. Gastroenterology 1991; 100: A17
   PubMedGoogle Scholar
• Katchinski B, Robe J, Bracht J, Goebell H. The influence of NSAID treatment on the prognosis of peptic ulcer bleeding. Gastroenterology 1992; 102: A16
   Google Scholar
• Armstrong C P, Blower A L. Ulcerogenicity of piroxicam: an analysis of spontaneously reported data. Br Med J 1987; 294: 772
   PubMedGoogle Scholar
• Piper J M, Ray W A, Daugherty J R, Griffin M R. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drug. Ann Intern Med 1991; 114: 735–40
   PubMed Web of Science ®Google Scholar
• FDA Drug Bulletin. February, 1989; 19: 3–4
   Google Scholar
• Smalley W E, Griffin M R, Daugherty J R. Hospitalization for ulcer-related diseases in the elderly Medicaid population. Gastroenterology 1992; 102: A25
   Google Scholar
• Fries J F, Williams C A, Bloch D A, Michel B A. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 1991; 91: 213–22
   PubMed Web of Science ®Google Scholar
• Faulkner G, Pritchard P, Somerville K, Langman M JS. Aspirin and bleeding peptic ulcers in the elderly. Br Med J 1988; 297: 1311–13
   PubMed Web of Science ®Google Scholar
• Holvoet J, Terriere L, Van Hee W, Verbist L, Fierens E, Hautekeete M L. Relation of upper gastrointestinal bleeding to nonsteroidal anti-inflammatory drugs and aspirin: a case-control study. Gut 1991; 32: 730–4
   PubMed Web of Science ®Google Scholar
• Rooney P J, Hunt R H. The risk of upper gastrointestinal hemorrhage during steroidal and nonsteroidal anti-inflammatory therapy. Balliere Clin Rheumatol 1990; 4: 207–17
   PubMedGoogle Scholar
• Levy M, Miller D R, Kaufman D W, et al. Major upper gastrointestinal tract bleeding: relation to the use of aspirin and other non-narcotic analgesics. Arch Intern Med 1988; 148: 281–5
   PubMedGoogle Scholar
• Pritchard P J, Kitchingman G K, Walk R P, Daneshmend T K, Hawkey C J. Human gastric mucoal bleeding induced by low dose aspirin, but not warfarin. Br Med J 1989; 298: 493–6
   PubMedGoogle Scholar
• Bellary S V, Isaacs P E, Lee F I. Upper gastrointestinal lesions in elderly patients presenting for endoscopy: relevance of NSAID use. Am J Gastroenterol 1991; 86: 961–4
   PubMedGoogle Scholar
• The Dutch T IA, Trial Study Group. A comparison of two doses of aspirin (30 mg v 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991; 325: 1261–6
   PubMedGoogle Scholar
• The S ALT, Collaborative Group. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischemic strokes. Lancet 1991; 338: 1345–9
   PubMed Web of Science ®Google Scholar
• Lanas A, Sekar M C, Hirschowitz B I. Objective testing reveals very strong association of ASA with upper and lower GI (i.e. ulcer and non-ulcer) bleeding. Gastroenterology 1992, In press
   PubMedGoogle Scholar
• Laporte J R, Carne X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to the previous use of analgesics and nonsteroidal anti-inflammatory drugs. Lancet 1991; 337: 85–9
   PubMed Web of Science ®Google Scholar
• Neil G A, Johlin F C, Garner L M, Zimmerman B. Risk factors associated with upper gastrointestinal bleeding–a case control study. Gastroenterology 1992; 102: A133
   Google Scholar
• Buring J E, Hennekens C H. Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease. Am J Gastroenterol 1991; 86: 1279–80
   PubMedGoogle Scholar
• Shorrock C J, Langman M JS, Warlow C. Risks of upper GI bleeding during TIA prophylaxis with aspirin. Gastroenterology 1992; 102: 165
   Google Scholar
• Graham D Y, Smith J L. Aspirin and the stomach. Ann Intern Med 1986; 104: 390–8
   PubMed Web of Science ®Google Scholar
• Antiplatelet Trialists Collaboration. Secondary prevention of vascular disease by prolonged anti-platelet treatment. Brit Med J 1988; 296: 320–4
   PubMed Web of Science ®Google Scholar
• Collier D, St J, Pain J A. Nonsteroidal anti-inflammatory drugs and peptic ulcer. Gut 1985; 26: 359–63
   PubMed Web of Science ®Google Scholar
• Walt R, Katchinski B, Logan R, Ashley J, Langman M JS. Rising frequency of peptic ulcer perforation in elderly people in the United Kingdom. Lancet 1986; 1: 489–92
   PubMed Web of Science ®Google Scholar
• Katschinski B D, Zachewitz H, Goebell H. Nonsteroidal anti-inflammatory drugs and mortality from peptic ulceration in West Germany. Dig Dis Sci 1992; 37: 385–9, 1952-89
   PubMed Web of Science ®Google Scholar
• Jick S J, Perera D R, Walker A M, Jick H. Nonsteroidal antiinflammatory drugs and hospital admission for perforated peptic ulcer. Lancet 1987; 2: 380–2
   PubMed Web of Science ®Google Scholar
• Jorgensen J G. Drug consumption before perforation of peptic ulcer. Br J Surg 1977; 64: 247–9
   PubMedGoogle Scholar
• Duggan J M. Aspirin ingestion and perforated peptic ulcer. Gut 1972; 13: 631–3
   PubMed Web of Science ®Google Scholar
• Thompson M R, Morris A F, Hughes A O. Indomethacin and perforated duodenal ulcer. Br Med J 1980; 280: 1618
   PubMedGoogle Scholar
• Donnelly P. Indomethacin and perforated duodenal ulcer. Br Med J 1980; 281: 230
   PubMedGoogle Scholar
• Langman M JS. Ulcer complications and nonsteroidal antiinflammatory drugs. Am J Med 1988; 84: 15–9, Suppl 2A
   PubMed Web of Science ®Google Scholar
• Ehsanullah R S, Page M C, Tildesley G, Wood J R. Prevention of gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs: controlled trial of ranitidine. Br Med J 1988; 297: 1017–21
   PubMed Web of Science ®Google Scholar
• Guess H A, West R, Strand L M, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and non-users of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol 1988; 41: 35–45, 1
   PubMed Web of Science ®Google Scholar
• Semble E L, Turner R A, Wu W C. Clinical and genetic characteristic of upper gastrointestinal disease in rheumatoid arthritis. J Rheumatol 1987; 14: 692–9
   PubMedGoogle Scholar
• Aird I, Bentall H H, Mehigan J A. The blood groups in relation to peptic ulceration, and carcinoma of the colon, rectum, breast and bronchus: an association between the ABO groups and peptic ulceration. Br Med J 1954; 2: 315–21
   PubMedGoogle Scholar
• George C J, Borody T J, Andrews P, Devine M, Moore-Jones D, Walton M. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990; 153: 145–9
   PubMed Web of Science ®Google Scholar
• Martin D F, Montgomery E, Dobeck A S, Peura D. Campylobacter pylori, NSAIDs, and smoking: risk factors for peptic ulcer disease. Am J Gastroenterol 1989; 84: 1268–72
   PubMed Web of Science ®Google Scholar
• McCarthy C J, McDermott M, Hourihane D, O'Morain C. A prospective histrological study of NSAID gastropathy and helicobacter pylori. Gastroenterology 1992; 102: A123
   Google Scholar
• McCarthy D M. Helicobacter pylori and gastroduodenal injury by non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1991; 26: 91–7, Suppl 187
   Web of Science ®Google Scholar
• Graham D Y, Lacey Smith J, Spjut H, Torres E. Gastric adaptation: studies in humans during continuous aspirin administration. Gastroentrology 1988; 95: 327–33
   PubMed Web of Science ®Google Scholar
• Shorrock C J, Rees W DW. Mucosal adaptation to indomethacin induced gastric damage in man–studies on morphology, blood flow, and prostaglandin E2 metabolim. Gut 1992; 33: 164–9
   PubMed Web of Science ®Google Scholar
• Loludice T A, Saleem T, Lang J A. Cimetidine in the treatment of gastric ulcer, induced by steroidal and non-steroidal anti-inflammatory agents. Am J Gastroenterol 1981; 75: 101–10
   Google Scholar
• Berkowitz J M, Rogenes P R, Sharp J T, Warner C W. Ranitidine protects against gastroduodenal damage associated with chronic aspirin therapy. Arch Interm Med 1987; 147: 2137–9
   PubMedGoogle Scholar
• Domschke W, Hagel J, Ruppin H, Kaduk B. Antacid protection of gastric mucosa. Klin Wochenschr 1986; 64: 28–31, Suppl 7
   PubMedGoogle Scholar
• Eastwood G L, Quimby G F. Effect of chronic aspirin ingestion on epithelial proliferation in rat fundus, antrum and duodenum. Gastroenterology 1982; 82: 852–6
   PubMed Web of Science ®Google Scholar
• Levi S, Goodlad R A, Lee C Y, Walport M J, Wright N A, Hodgson H JF. Effects of nonsteroidal anti-inflammatory drugs and misoprostol on gastroduodenal epithelial proliferation in arthritis. Gastroenterology 1992; 102: 1605–11
   PubMed Web of Science ®Google Scholar
• Levi S, Goodlad R A, Lee C Y, et al. Inhibitory effect of nonsteroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990; 336: 840–3
   PubMed Web of Science ®Google Scholar